Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Liabilities and Shareholders Equity (2021 - 2025)

PAVmed has reported Liabilities and Shareholders Equity over the past 5 years, most recently at $38.8 million for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $38.8 million for Q4 2025, up 26.59% from a year ago — trailing twelve months through Dec 2025 was $173.6 million (up 31.14% YoY), and the annual figure for FY2025 was $38.8 million, up 26.59%.
  • Liabilities and Shareholders Equity for Q4 2025 was $38.8 million at PAVmed, up from $38.1 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for PAVM hit a ceiling of $87.0 million in Q4 2021 and a floor of $25.0 million in Q3 2024.
  • Median Liabilities and Shareholders Equity over the past 5 years was $45.6 million (2021), compared with a mean of $51.1 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 74.06% in 2022 and later crashed 42.94% in 2024.
  • PAVmed's Liabilities and Shareholders Equity stood at $87.0 million in 2021, then plummeted by 37.94% to $54.0 million in 2022, then plummeted by 38.65% to $33.1 million in 2023, then decreased by 7.42% to $30.7 million in 2024, then increased by 26.59% to $38.8 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $38.8 million (Q4 2025), $38.1 million (Q3 2025), and $43.9 million (Q2 2025) per Business Quant data.